Apixaban shows less bleeding risk than rivaroxaban in venous thrombosis treatment
In terms of clinically relevant bleeding, apixaban is safer than rivaroxaban in the treatment of venous thrombosis, researchers concluded on March 11, 2026 in the NEJM/New England Journal of… read more.




